Articles On Genetic Technologies (ASX:GTG)

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX has finished 0.5% ahead, despite Wall Street’s flabby performance on Friday. Health Care has taken a positive 1.8% step towards fixing last week’s -6.1% disaster. Gold 50 has topped the charts after hitting stellar intercepts at its Ar...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

S&P/ASX 200 closes up 0.35% ending three day losing streak, Emerging Companies index up .10% Limeade surges more than 300% after announcing $112 million takeover by by US-based Web Health Services MQR and MinRes accelerate their farm-i...

Real estate, tech and specialty retail have all had a shocker on the way to an overall 0.26% fall Energy put up a 1.5% gain, with Utilities (+1.0%) and Materials (+0.6%) following it home Best of the Small Caps was Iceni Gold, after testin...

Aussie markets ended the day 0.16% lower, because someone raised interest rates yesterday Investors are running back into the safe haven arms of the goldies, while the tech sector shines Two little Small Cappers made triple-digit gains tod...

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

Early 1.37% benchmark jump slides slowly to land at +0.88% Real Estate leads on +1.89%, with Consumer Discretionary in last, down 0.59% Signs of lithium-bearing pegmatites at Kirup boost Kula Gold by 42.6%   Well, it’s that time of the da...

The ASX closed out the day flat, thanks to a last-minute selling spree Qantas announces record profit but still won’t give us back the money we gave them during Covid Westar Resources won the Small Caps race, in spite of a 90-minute hobbli...

ASX sinks to -0.4% before slogging its way back to -0.22% for the day. Tech stocks were all over the shop but came out on top with +1.2%. Wildcat (ASX:WC8) was King of the Small Caps, adding 34.5% on no fresh news.   After sinking as low...

S&P/ASX 200 closes flat up just 0.07%, while the emerging companies index falls 0.48% Cellnet Group up 44% after a takeover bid by German private company Wentronic Holding GmbH Podium Minerals completes $2 million cap raise to advance...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

An afternoon rally has put some lead back in the market’s pencil, closing down 0.08%. Tech stocks and Small Ordinaries drive the wins, with InfoTech up 1.5% for the day. Lithium’s back on the menu, with three big names making some chunky,...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 benchmark has posted a solid slab of gains, up 0.78% for the day Energy and Materials have teamed up to bring the winnings, at +2.5% and +1.6% respectively Creso Pharma’s buy-out of HHI delivers strong backing from investors, u...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

After rallying back from -0.5% all day, the ASX finished basically flat, -0.06% from break-even Financials sucked but the rest of the market did well, and gold hit a record high above AUD$3,000/oz Lithium explorer Greenwing posts an unexp...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The S&P ASX 200 closed up 0.2%, while the S&P XEC fell 0.61% Polymetal Resources soars 64% after announcing thick high grade drill hits at Endeavour polymetallic mine XTEK subsidiary HighCom Armour Solutions signs a collaboration d...

ASX was poised to finish flat, but managed to squeeze out a 1.2 point jump at the bell Goldies have soared again, thanks to spot gold prices rising back above US$2000 an ounce Western Mines Group defies the odds, cranking out a 186% rocket...

The ASX jumped 0.3% after lunch as the RBA finally kept rates on hold. XGD All Ordinaries Gold soared ~3.0% because someone missed a memo. Besra Gold is back on top with a 36% leap after Quantum’s cheque cleared customs.   Local markets w...

ASX closes up 0.78%, while XEC rises 1.91% following global markets higher Morningstar warns of possible start of US recession next week spanning 3 quarters, but talk of pause in Aussie rate hikes ‘premature’ Hubify subsidiary Broadland So...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 was up 0.23% while the ASX XEC managed a 0.092% gain 8 out of 11 sectors were higher with Materials leading the way  The Real Estate sector was the weakest, down 0.77%   The ASX 200 was up 0.23% today while the ASX XEC squeez...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ImpediMed surges as the US NCCN included bioimpedance spectroscopy (BIS) as part new guidelines ImpediMed has the only FDA-cleared BIS technology for the assessment of lymphoedema GTG adds 3 new diseases to its geneType Multi-Test   Imped...

ASX down, then up, then down even further to -1.4% as bank crisis looms large. XEC Emerging Companies index plummets 1.8% as fear overtakes greed. Goldies are making hay again, XED All Ordinaries Gold up more than 7.0%.   Things have been...

The ASX bounced back from the week’s drama to close up by 0.86% The XEC Emerging Companies Index closed 1.26% higher because it’s young and needed the money Former PM Paul Keating kicks a glorious own goal at the Australian Press Club   H...

ASX weathers a US bank collapse storm to finish the day down just 0.5% XEC Emerging Companies index down 0.84% because it was out partying all weekend. The Goldies take the gongs, after the precious metal jumped more than 1.0%   Looking a...

Neuren Pharma gets a ‘historic’ FDA approval for DAYBUE to treat Rett syndrome Genetic Technologies published another research paper HITIQ sells 200 Nexus Head Impact Sensors to Monash University   Neuren Pharmaceuticals (ASX:NEU) surged...

ASX 200 adds just 0.1% because it was literally the least it could do. Aussie tech stock surge negated by Doctors and Miners having a bad hair day. Two ASX-listed lithium players are under attack over alleged corruption in Africa, of all p...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX scuttled by bleak rates outlook in the US, down 0.83% for the day RBA boss Philip Lowe had better news for Aussies. Kind of Summit Resources galloped to a win, up 35% on great REE news at Stallion   We have comments from US Fed chair...

The ASX spikes on ‘news’ that the RBA has pushed rates up again, closing at +0.6% Invocare has risen from the grave after a bit to buy up the funeral company China finally breaks Errol Flynn’s world record for rattling sabres, terrifying K...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Highlights Imugene has advanced its ongoing Phase 1 MAST study with the first patients receiving dosing in the intratumoral (IT) and intravenous (IV) cohorts of CF33-hNIS in combination with Pembrolizumab. The study is focused on measu...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX got an Data Nerd Bailout when the ABS dropped happy-ish CPI data The benchmark recovers from early flesh wounds to end the day flat Ordinary Aussies ‘outraged’ over changes to super that will never, ever affect them The market has...

The ASX climbed 0.4% today after investors threatened it with a stick Mt Monger (ASX:MTM) wins the day by securing funding for it’s Canadian REE play New consumer survey suggests 42% of shoppers might be dumber than previously feared   Au...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX fell today because US data gave Wall Street the willies on Friday A month’s worth of shipping data shows coal shipments to China are on the rise Qantas celebrates last week’s $1bn profit by slashing regional services. Again   Toda...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX recovered from an early stumble to finish the day up-ish Meta wants you to pay $12 a month for the privilege of being a captive audience Some Big Names have had shockers as earnings relentlessly keep rolling in   The benchmark has...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 climbs about 0.8% on a happier day than yesterday Unemployment jump to 3.7% in January eases concern over future rate rise severity NSW Government’s coal policy kicks miners square in the cokers   Good afternoon, and welcome to th...

Genetic Technologies (ASX:GTG) has announced the publication of a new research paper in the peer-reviewed journal Breast Cancer Research and Treatment.